Skip to content
Lower risk Medical device recall · FDA · Published June 10, 2022

Invacare Platinum 5NXG Oxygen Concentrator Recall: Missing Rx Only Label

Invacare recalls specific Canada models of oxygen concentrators due to missing 'Rx Only' label on product labels produced between March 2021 and December 2021. Affected units have serial number prefixes starting with 21F, 21J, 21G, 21K, 21H, or 21L.

🇺🇸 FDA recall #Z-1369-2022Medical deviceInvacare ›
Take action

Contact the company

Recalling firmInvacare Corporation1200 Taylor St · Elyria, OH 44035-6248
✎ GovInfoNow plain-language explainer

What happened, in plain English

Invacare is recalling certain Canada-specific oxygen concentrators because the product labels produced between March 2021 and December 2021 did not include the required 'Rx Only' statement. This could lead to improper use if the device is not prescribed by a healthcare provider. Read more at govinfonow.com/recall/60514-invacare-platinum-5nxg-oxygen-concentrator-recall-missing-rx-only-label.

Source Summary by GovInfoNow · govinfonow.com/recall/60514-invacare-platinum-5nxg-oxygen-concentrator-recall-missing-rx-only-label · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1369-2022

Cite this page

“Invacare Platinum 5NXG Oxygen Concentrator Recall: Missing Rx Only Label.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/60514-invacare-platinum-5nxg-oxygen-concentrator-recall-missing-rx-only-label. Based on FDA recall #Z-1369-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1369-2022%22&limit=1).

Why it’s dangerous

The product label did not contain the required 'Rx Only' statement as mandated by regulations. This means the device might be used by individuals who are not prescribed for it, potentially leading to unsafe medical use.

Who’s affected

People in Canada who own or use the Invacare Platinum 5NXG Oxygen Concentrator with model numbers P5NXG1 or P5NXGC1 are affected. Those who have the specific serial number prefixes listed are most at risk.

How to tell if you have this one

Check for the model numbers P5NXG1 or P5NXGC1 on the device. Look for serial number prefixes starting with 21F, 21J, 21G, 21K, 21H, or 21L. These units were produced between March 2021 and December 2021 in Canada.

  • Brand
    Invacare
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Verify the model number and serial number prefixes to confirm if the device is affected.

Where it went and when

Where it was distributed

Distributed in 18 states.

Alaska: yesAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: yesIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: yesMNIllinois: not listedILWisconsin: not listedWIMichigan: yesMINew York: yesNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: yesIAIndiana: not listedINOhio: yesOHPennsylvania: yesPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: yesCONebraska: not listedNEMissouri: yesMOKentucky: yesKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: yesAZNew Mexico: not listedNMKansas: yesKSArkansas: not listedARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: yesOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: yesGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Domestic distribution to the following states: ALASKA ARIZONA CALIFORNIA COLORADO GEORGIA IDAHO IOWA KANSAS KENTUCKY MICHIGAN MINNESOTA MISSOURI NEW YORK NORTH CAROLINA OHIO OKLAHOMA PENNSYLVANIA TENNESSEE” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Alaska, Arizona, California, Colorado, Georgia, Idaho, Iowa, Kansas, Kentucky, Michigan, Minnesota, Missouri, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Tennessee.

Recall timeline

FDA published this recall 40 days after the firm started it.

1. Firm started the recall: Jun 10, 202212. FDA classified it Class III: Jul 12, 202223. Published in FDA’s Enforcement Report: Jul 20, 202232022
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1369-2022 (June 10, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1369-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA